Back
Results - Announcements
Sales rise 128.01% to Rs 9.28 crore
Parmax Pharma reports standalone net loss of Rs 0.22 crore in the September 2024 quarter
16-Nov-2024, 07:38
Net Loss of Parmax Pharma reported to Rs 0.22 crore in the quarter ended September 2024 as against net loss of Rs 1.37 crore during the previous quarter ended September 2023. Sales rose 128.01% to Rs 9.28 crore in the quarter ended September 2024 as against Rs 4.07 crore during the previous quarter ended September 2023.
Net Loss of Parmax Pharma reported to Rs 0.22 crore in the quarter ended September 2024 as against net loss of Rs 1.37 crore during the previous quarter ended September 2023. Sales rose 128.01% to Rs 9.28 crore in the quarter ended September 2024 as against Rs 4.07 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended | ||
| Sep. 2024 | Sep. 2023 | % Var. | |
| Sales | 9.28 | 4.07 | 128 |
| OPM % | 2.05 | -18.92 | - |
| PBDT | 0.18 | -0.94 | LP |
| PBT | -0.22 | -1.37 | 84 |
| NP | -0.22 | -1.37 | 84 |
Powered by Capital Market - Live News